interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Brensocatib

Generic competition · all medicines · read 12 November 2026

Is there a generic of Brensocatib, and who makes it?

Brensocatib appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Brensocatib1 dosage-form group in the Orange Book
0generic makers listed
  1. Brensocatib appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Brinsupri. No generic is listed as marketed.

2020202520302035204001brand 2025data datePatent 12054465 listed to expire 21 January 2035Patent 11814359 listed to expire 21 January 2035Patent 11773069 listed to expire 21 January 2035Patent 11673871 listed to expire 21 January 2035Patent 11655224 listed to expire 21 January 2035Patent 11655223 listed to expire 21 January 2035Patent 11655222 listed to expire 21 January 2035Patent 11655221 listed to expire 21 January 2035Patent 10669245 listed to expire 21 January 2035Patent 10287258 listed to expire 21 January 2035Patent 9815805 listed to expire 21 January 2035Patent 9522894 listed to expire 12 March 2035Patent 12201638 listed to expire 1 March 2039Patent 12059424 listed to expire 21 February 2040Exclusivity NCE to 12 August 2030
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 12 August 2030Exclusivity NCE Brinsupri
  • 21 January 2035Patent 12054465 drug substance
  • 21 January 2035Patent 11814359 drug substance
  • 21 January 2035Patent 11773069 drug product
  • 21 January 2035Patent 11673871 drug product
  • 21 January 2035Patent 11655224 drug product
  • 21 January 2035Patent 11655223 drug substance
  • 21 January 2035Patent 11655222 drug substance
  • 21 January 2035Patent 11655221 drug product

6 more patents are listed.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.